The accessibility tree decides whether an AI agent can read and act on your page. The 2026 data says the web is getting ...

By allowing lawsuits to proceed, a federal judge may be opening the door to broader liability for AI tool vendors, and greater governance obligations for enterprises using them.

In 2026, artificial intelligence is no longer a futuristic concept in healthcare, it’s actively working alongside dentists across the country. The American Dental Association has been at the forefront ...

This is a developing story. Check back to sanluisobispo.com for updates. To get breaking news alerts, click here A vegetation fire burning in the hills east of Templeton threatened structures Saturday ...

Cardano active addresses have spiked for the second time this month as ADA trades near 2020 lows. A Cardano-based wallet protocol was exploited for nearly 129 million ADA, worth roughly $20 million.

Ranked by market capitalization at the time of writing (June 26, 2026, mid-correction prices), the ten largest ...

Boehringer Ingelheim revealed more data behind previously reported top-line results for its dual-acting obesity drug survodutide, including strong activity against visceral and liver fat. The efficacy ...

New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...

Cardano whales kept buying ADA in late June even as transactions, smart contract use, and fees fell to a 45-day low.

CAMBRIDGE, Mass., June 8, 2026 /PRNewswire/ --MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the presentation of ...

AstraZeneca is preparing to move its oral GLP-1 agonist elecoglipron into a phase 3 programme in obesity and type 2 diabetes, after reporting encouraging mid-stage results. The results of the phase 2b ...

NEW ORLEANS -- In the wake of clinicians and researchers being kicked out of the American Diabetes Association (ADA) meeting here, at least two of the organization's leaders have resigned.